INVO BioScience, Inc.INVO BioScience, Inc.INVO BioScience, Inc.

INVO BioScience, Inc.

No trades
See on Supercharts
Market capitalization
‪4.17 M‬USD
−8.66USD
‪−8.03 M‬USD
‪3.02 M‬USD
‪2.72 M‬
Beta (1Y)
0.44

About INVO BioScience, Inc.

CEO
Steven M. Shum
Headquarters
Sarasota
Employees (FY)
30
Founded
2007
ISIN
US44984F4019
FIGI
BBG000GHH9P9
INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INVO is 1.52 USD — it has decreased by 16.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange INVO BioScience, Inc. stocks are traded under the ticker INVO.
INVO BioScience, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
INVO stock is 36.84% volatile and has beta coefficient of 0.44. Check out the list of the most volatile stocks — is INVO BioScience, Inc. there?
INVO earnings for the last quarter are −0.56 USD per share, whereas the estimation was −0.99 USD resulting in a 43.25% surprise. The estimated earnings for the next quarter are −0.87 USD per share. See more details about INVO BioScience, Inc. earnings.
INVO BioScience, Inc. revenue for the last quarter amounts to ‪1.35 M‬ USD despite the estimated figure of ‪997.11 K‬ USD. In the next quarter revenue is expected to reach ‪1.93 M‬ USD.
Yes, you can track INVO BioScience, Inc. financials in yearly and quarterly reports right on TradingView.
INVO stock has risen by 85.37% compared to the previous week, the month change is a 49.02% rise, over the last year INVO BioScience, Inc. has showed a 83.15% decrease.
INVO net income for the last quarter is ‪−1.99 M‬ USD, while the quarter before that showed ‪−1.25 M‬ USD of net income which accounts for −59.78% change. Track more INVO BioScience, Inc. financial stats to get the full picture.
Today INVO BioScience, Inc. has the market capitalization of ‪4.17 M‬, it has decreased by 6.75% over the last week.
No, INVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVO BioScience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
INVO reached its all-time high on Nov 28, 2008 with the price of 5440.00 USD, and its all-time low was 0.50 USD and was reached on Oct 19, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 30.00 employees. See our rating of the largest employees — is INVO BioScience, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INVO BioScience, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INVO BioScience, Inc. stock shows the sell signal. See more of INVO BioScience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INVO BioScience, Inc. EBITDA is ‪−6.51 M‬ USD, and current EBITDA margin is −217.38%. See more stats in INVO BioScience, Inc. financial statements.